CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
P/S ratio for CytomX Therapeutics (CTMX)
P/S ratio as of May 2024 (TTM): 1.54
According to CytomX Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.5397. At the end of 2023 the company had a P/S ratio of 1.03.
P/S ratio history for CytomX Therapeutics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.03 | -67.03% |
| 2022 | 3.11 | -23.39% |
| 2021 | 4.06 | 28.95% |
| 2020 | 3.15 | -52.14% |
| 2019 | 6.58 | -42.48% |
| 2018 | 11.4 | 1.06% |
| 2017 | 11.3 | -57.43% |
| 2016 | 26.6 | -72.73% |
| 2015 | 97.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |